Episode from the podcastScience Magazine Podcast

FDA clinical trial failures, and an AI that can beat curling’s top players

Released Thursday, 1st October 2020
Good episode? Give it some love!
Investigative journalist Charles Piller joins host Sarah Crespi to discuss his latest Science exclusive: a deep dive into the Food and Drug Administration’s protection of human subjects in clinical trials. Based on months of data analysis and interviews, he uncovered long-term failures in safety enforcement in clinical trials and potential problems with trial data used to make decisions about drug and device approvals.

Sarah also talks with Klaus-Robert Müller, a professor of machine learning at the Technical University of Berlin, about an artificial intelligence (AI) trained in the sport of curling—often described as a cross between bowling and chess. Although AI has succeeded in chess, Go, and poker, the constantly changing environment of curling is far harder for a nonhuman mind to adapt to. But AIs were the big winners in competitions with top human players, Müller and colleagues report this week in Science Robotics.

This week’s episode was produced with help from Podigy.

Listen to previous podcasts.

About the Science Podcast

Download a transcript (PDF).

Creators & Guests

We don't know anything about the creators of this episode yet. You can add them yourself so they can be credited for this and other podcasts.

Episode Reviews

This episode hasn't been reviewed yet. You can add a review to show others what you thought.

This podcast, its content, and its artwork are not owned by, affiliated with, or endorsed by Podchaser.
Rate Episode

Share This Episode

Recommendation sent

Join Podchaser to...

  • Rate podcasts and episodes
  • Follow podcasts and creators
  • Create podcast and episode lists
  • & much more

Episode Details

Length
28m 36s
Explicit
No

Episode Tags

Do you host or manage this podcast?
Claim and edit this page to your liking.